Korea Investment Corp
CRSP icon

Korea Investment Corp’s CRISPR Therapeutics CRSP Stock Holding History

Korea Investment Corp’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-45,300
Closed -$1.86M – 652
2019
Q3 		$1.86M Buy
45,300
+1,500
+3% +$71.7K 0.01% 531
2019
Q2 		$2.06M Sell
43,800
-4,100
-9% -$164K 0.01% 525
2019
Q1 		$1.71M Hold
47,900
– – 0.01% 556
2018
Q4 		$1.37M Hold
47,900
– – 0.01% 532
2018
Q3 		$2.12M Sell
47,900
-7,900
-14% -$414K 0.01% 517
2018
Q2 		$3.28M Buy
+55,800
New +$3.18M 0.01% 538

Other funds holding CRSP

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Korea Investment Corp's CRSP Position: Q4 2019 in Review

Korea Investment Corp sold out of CRISPR Therapeutics (CRSP) in Q4 2019, closing a stake of 45,300 shares — an estimated $1.86M sold.

Korea Investment Corp first reported a position in CRSP in Q2 2018 and held it in 6 quarters. The position peaked at $3.28M in Q2 2018. 253 funds tracked by Wall St. Rank hold CRSP as of Q4 2019.

  • Korea Investment Corp reported no remaining CRISPR Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Korea Investment Corp sold 45,300 CRISPR Therapeutics shares in Q4 2019, an estimated $1.86M.
  • Korea Investment Corp first reported a position in CRISPR Therapeutics in Q2 2018 and held it in 6 quarters.
  • Korea Investment Corp's CRISPR Therapeutics position peaked at $3.28M in Q2 2018.
  • 253 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q4 2019.

Based on Korea Investment Corp's 13F filing for Q4 2019, filed 11 Feb 2020.